Global iPSC market projected to reach $5.74 billion by 2030 at 9.3% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Induced Pluripotent Stem Cell (iPSC) Market Grow Between 2026 And 2030?

The induced pluripotent stem cell (ipsc) market has experienced substantial expansion over the past few years. Its valuation is expected to rise from $3.67 billion in 2025 to $4.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.5%. This historical increase can be ascribed to advancements in cellular reprogramming studies, ethical considerations surrounding embryonic stem cells, increased financial backing for stem cell research, an expansion in academic research collaborations, and the rising occurrence of chronic and degenerative conditions.

The induced pluripotent stem cell (ipsc) market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $5.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. Several factors are contributing to this expansion during the forecast timeframe, including the broadening of regenerative medicine applications, a heightened need for personalized treatments, increasing capital invested in cell and gene therapies, the growing use of ipscs in studies related to neurological and cardiac conditions, and supportive regulatory frameworks for advanced therapeutic approaches. Key developments expected within this period encompass the increasing application of ipscs in creating disease models, their wider integration into drug discovery and assessments of toxicity, the expansion of methods for developing patient-specific cell lines, a greater emphasis on finding ethical substitutes for embryonic stem cells, and improvements in the effectiveness of reprogramming as well as cellular stability.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

What Primary Drivers Are Shaping The Induced Pluripotent Stem Cell (iPSC) Market?

The rising occurrence of neurological disorders is anticipated to propel the expansion of the induced pluripotent stem cell market. A neurological disorder refers to a medical condition impacting the nervous system, which includes the brain, spinal cord, and nerves. Prevalent examples of such disorders are acute spinal cord injury, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS). Pluripotent stem cells present significant potential for investigating disease mechanisms and conducting drug testing, thereby offering deeper insights into the origins of neurological disorders and aiding in the creation of regenerative therapies for conditions like Parkinson’s and Alzheimer’s disease. For instance, in October 2023, the World Federation of Neurology (WFN), an international nonprofit neurological organization based in the UK, stated that more than 40% of the global population was living with a neurological condition, and the overall neurological disease burden is projected to nearly double by 2050. Therefore, the increasing prevalence of neurological disorders is a key driver for the growth of the induced pluripotent stem cell market.

What Are The Main Segments Within The Induced Pluripotent Stem Cell (iPSC) Market Segment Structure?

The induced pluripotent stem cell (ipsc) market covered in this report is segmented –

1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

3) By End-User: Hospitals, Research Laboratories

Subsegments:

1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

What Trends Are Affecting The Growth Of The Induced Pluripotent Stem Cell (iPSC) Market?

Major companies in the induced pluripotent stem cell (IPSC) market are collaborating to advance iPSC technology, with the goals of enhancing regenerative medicine applications, improving disease modeling, accelerating drug discovery, and developing personalized therapeutic solutions. Induced Pluripotent Stem Cell (iPSC) technology refers to the scientific processes and methods used to reprogram adult somatic cells, such as skin or blood cells, back into a pluripotent state, making them capable of differentiating into any cell type in the body. For instance, in April 2024, SCG Cell Therapy Pte Ltd, a Singapore-based biotechnology company, and the Agency for Science, Technology and Research, a Singapore-based Statutory board, launched joint laboratories focused on advancing cellular immunotherapies. This initiative is supported by close to S$30 million, highlighting Singapore’s commitment to progressing biotechnology and healthcare solutions. The collaboration intends to develop scalable manufacturing processes for GMP-grade iPSC products, addressing the challenges of translating laboratory innovations into clinically viable therapies.

Who Are The Companies Participating In The Induced Pluripotent Stem Cell (iPSC) Market?

Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

Get The Full Induced Pluripotent Stem Cell (iPSC) Market Report:

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Which Region Leads The Induced Pluripotent Stem Cell (iPSC) Market In Terms Of Market Share?

North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Induced Pluripotent Stem Cell (iPSC) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2026, By The Business Research Company

Stem Cell Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Human Embryonic Stem Cells Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

Stem Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795